Kinyarwanda
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Wang Liang

Umutwe: Umuganga Mukuru
Umwanya: Umuyobozi w'Ishami
Umwirondoro we bwite: Umuganga Mukuru, Porofeseri, Umuyobozi wa Ph.D., ubu ni Umuyobozi w'Ishami ry'Ubumenyi bw'amaraso mu Bitaro bya Peking Tongren. Yarangije muri Peking Union Medical College mu 2010, yiga mu Buvuzi bw'Indwara mu myaka umunani, kandi yabonye impamyabumenyi y'Ubuganga. Amaze imyaka irenga 10 akora mu gusuzuma no kuvura ibibyimba by'amaraso (lymphoma, multiple myeloma, nibindi), kandi afite uburambe bwinshi mu buvuzi n'ubumenyi bwinshi mu gusuzuma no kuvura ubwoko butandukanye bwa lymphoma na myeloma, kandi yiga cyane mu kuvura indwara zishingiye ku bushobozi bwo kwirinda indwara, chimiotherapie, CAR-T cell therapy, gutera uturemangingo tw'amaraso, no kuyobora iterambere ry'isuzuma n'ubuvuzi bw'indwara zitandukanye (MDT). Ubushakashatsi bwe bw'ingenzi ni uburyo bwo kuvura indwara zishingiye ku bushobozi bwo kwirinda indwara no gushakisha uburyo bwo kurwanya imiti ya lymphoma, kandi yayoboye itsinda ry'Ikigo cy'Igihugu cy'Ubumenyi bw'Inyamaswa cy'Ubushinwa. Yasohoye inyandiko zirenga 40 z’umwuga, harimo inyandiko zirenga 30 za SCI-indexed, zasohotse muri Lancet Haematology, Journal of Hematology & Oncology, Leukemia, Clinical Cancer Research, Cancer Treatment Reviews, Cancer Therapy Reviews, n’ibindi binyamakuru n’ibinyamakuru. Yasohoye muri Lancet Haematology, Journal of Hematology & Oncology, Leukemia, Clinical Cancer Research, Cancer Treatment Reviews, Cancer, British Journal of Cancer, Annals of Hematology, na Leukemia & Lymphoma. Ni umwanditsi wungirije wa Standard Leukemia Diagnosis and Treatment, Standard Multiple Myeloma Diagnosis and Treatment, na Medical Oncology. Yahawe igihembo cya “Respect for Life-2017 Glory to Healers-Youth Innovation Award”, igihembo cya “Tongren Elite” mu 2020, igihembo cya “Tongren Hospital Outstanding Young Talent” mu 2020, n'igihembo cya mbere cya “Tongren Hospital Outstanding Young Talent” mu 2020. Tongren Hospital Outstanding Young Talent” mu 2020, '35 Young Oncologists Under 35 Within More Potential in China'. Amashami y'amasomo: Ukiri muto mu ishami rya Hematology ry'ishyirahamwe ry'abaganga b'Abashinwa; Ukiri muto mu itsinda rya Komite ishinzwe kurwanya immunotherapy ya Lymphoma y'ishyirahamwe rishinzwe gukumira no kurwanya kanseri rya Beijing; Ukiri muto mu itsinda rya Komite ya Myeloma y'ishyirahamwe ry'uburezi bw'ubuvuzi bw'Abashinwa; Impuguke mu ishami ry'igihugu ry'ubumenyi karemano mu Bushinwa. Ni umwanditsi wungirije wa Aging Pathobiology and Therapeutics, umunyamuryango w'inama y'ubwanditsi ya Journal of Chinese Prevention and Control, umunyamuryango w'inama y'ubwanditsi ya Concord Medical Journal, akaba n'umusesenguzi wa Journal of Hematology & Oncology and Cancer Biology & Medicine.

Wang Liang